NEWS
Tags: 

Pfizer has joined Accelrys consortium

Pfizer has joined the Accelrys Enterprise Cheminformatics Consortium – a collaborative project to develop cheminformatics software components and services for commercial companies.

Mark Emkjer, president and CEO of Accelrys, explained the importance of such a collaboration: ‘Close partnership and collaboration with industry is essential for Accelrys to develop software and services that help solve critical research problems.’

This is the latest in a long line of successful consortia led by Accelrys, which have worked in areas such as catalysis, combinatorial chemistry and nanotechnology. Consortium members collaborate in directing research and development activities to solve business issues, and have exclusive use of the resulting products for some time afterwards.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Analysis and opinion
Feature

Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets

Feature

Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users

Analysis and opinion